Showing 51–75 of 1,012 international scientific journals (Medicine)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Annales D Endocrinologie ISSN: 0003-4266 / 2213-3941 | 🇫🇷France | Q2 | CAS Tier 3 | 3.4 | 0.842Q2 | 35 | 42 | 3.4% | Elsevier Masson | Profile |
| 52 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.4 | 1.129Q1 | 80 | 102 | 3.4% | American Association for Cancer Research Inc. | Profile |
| 53 | Clinical & Translational Immunology ISSN: 2050-0068 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.4 | 1.312Q1 | — | 123 | 2.2% | Wiley-Blackwell | Profile |
| 54 | Endocrine Connections ISSN: 2049-3614 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.4 | 1.053Q2 | 12 | 188 | 3.8% | BioScientifica Ltd. | Profile |
| 55 | Expert Opinion on Pharmacotherapy ISSN: 1465-6566 / 1744-7666Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.4 | 0.765Q2 | 69 | 166 | 4% | Taylor and Francis Ltd. | Profile |
| 56 | Hypertension in Pregnancy ISSN: 1064-1955 / 1525-6065 | 🇺🇸United States | Q1 | CAS Tier 4 | 3.4 | 0.736Q2 | 42 | 38 | 0% | Informa Healthcare | Profile |
| 57 | Infection and Immunity ISSN: 0019-9567 / 1098-5522 | 🇺🇸United States | Q3 | CAS Tier 3 | 3.4 | 1.171Q1 | 204 | 246 | 3.4% | American Society for Microbiology | Profile |
| 58 | International Immunology ISSN: 0953-8178 / 1460-2377 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.4 | 1.354Q1 | 124 | 90 | 2.1% | Oxford University Press | Profile |
| 59 | Journal of Leukocyte Biology ISSN: 0741-5400 / 1938-3673 | 🇺🇸United States | Q3 | CAS Tier 3 | 3.4 | 1.203Q2 | 175 | 171 | 0% | John Wiley & Sons Inc. | Profile |
| 60 | Journal of the American Medical Directors Association ISSN: 1525-8610 / 1538-9375Top Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 3.4 | 1.205Q1 | 75 | 384 | 7.1% | Elsevier Inc. | Profile |
| 61 | Molecular and Cellular Endocrinology ISSN: 0303-7207 / 1872-8057 | 🇳🇱Netherlands | Q3 | CAS Tier 3 | 3.4 | 1.232Q1 | 131 | 300 | 2.6% | Elsevier Ireland Ltd | Profile |
| 62 | Mycoses ISSN: 0933-7407 / 1439-0507 | 🇩🇪Germany | Q2 | CAS Tier 2 | 3.4 | 0.85Q1 | 62 | 166 | 4.9% | Wiley-Blackwell Publishing Ltd | Profile |
| 63 | Vaccine ISSN: 0264-410X / 1358-8745 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.4 | 1.186Q1 | 164 | 926 | 6.7% | Elsevier BV | Profile |
| 64 | Adipocyte ISSN: 2162-3945 / 2162-397X | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.3 | 0.974Q1 | 9 | 57 | 2.9% | Taylor and Francis Ltd. | Profile |
| 65 | Antiviral Therapy ISSN: 1359-6535 / 2040-2058 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.3 | 0.836Q2 | 78 | 17 | 0% | International Medical Press Ltd | Profile |
| 66 | BMC Neuroscience ISSN: 1471-2202 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.3 | 0.865Q2 | 86 | 73 | 4.2% | BioMed Central | Profile |
| 67 | Cns & Neurological Disorders-Drug Targets ISSN: 1871-5273 / 1996-3181 | 🌐United Arab Emirates | Q2 | CAS Tier 3 | 3.3 | 0.789Q2 | 78 | 70 | 3.7% | Bentham Science Publishers B.V. | Profile |
| 68 | Diabetic Medicine ISSN: 0742-3071 / 1464-5491 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 3.3 | 1.297Q1 | 132 | 215 | 6.2% | Wiley-Blackwell Publishing Ltd | Profile |
| 69 | Endocrine ISSN: 0969-711X | 🌐International | Q3 | CAS Tier 3 | 3.3 | — | — | 103 | 6.7% | Updating | Profile |
| 70 | Immunology and Cell Biology ISSN: 0818-9641 / 1440-1711 | 🌐Australia | Q3 | CAS Tier 4 | 3.3 | 1.079Q2 | 96 | 55 | 6.2% | John Wiley & Sons Inc. | Profile |
| 71 | Interactive Journal of Medical Research ISSN: 1929-073X | 🌐Canada | Q2 | CAS Tier 3 | 3.3 | — | — | 14 | 0% | JMIR Publications | Profile |
| 72 | Journal of Asthma and Allergy ISSN: 1178-6965 | 🌐New Zealand | Q2 | CAS Tier 3 | 3.3 | 0.983Q1 | — | 139 | 2.7% | Dove Medical Press | Profile |
| 73 | Journal of Integrative Neuroscience ISSN: 0219-6352 / 1757-448X | 🌐Singapore | Q2 | CAS Tier 3 | 3.3 | 0.8Q2 | 29 | 106 | 4% | IMR Press | Profile |
| 74 | Journal of Neuropsychiatry and Clinical Neurosciences ISSN: 0895-0172 / 1545-7222 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.3 | 0.827Q2 | 101 | 40 | 8.3% | American Psychiatric Publishing Inc. | Profile |
| 75 | Lung Cancer: Targets and Therapy ISSN: 1179-2728 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.3 | — | — | 8 | N/A | Dove Medical Press | Profile |